Skip to content

HelloBetter - Endometriosis study

HelloBetter - Endometriosis study - ACTonENDO

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038806
Enrollment
260
Registered
2026-05-12
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Intervention group Participants in the intervention group will receive direct, free access to the online therapy program HelloBetter Endometriosis. HelloBetter Endometriosis consists of 7 mod

Sponsors

Universität Duisburg-Essen
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - medically confirmed diagnosis of endometriosis - significant pain impairment (at least grade 1 severity according to the Graded Chronic Pain Scale by Korff) - sufficient internet access and an appropriate device - sufficient german language skills

Exclusion criteria

Exclusion criteria: Substantial suicide risk measured at baseline by Item 9 of the BDI-II (Score >1)

Design outcomes

Primary

MeasureTime frame
The primary outcome is pain-related interference, assessed using the MPI. The questionnaire is administered online. Baseline assessment is conducted prior to randomization, and the post-intervention assessment takes place 12 weeks after study inclusion.

Secondary

MeasureTime frame
Confirmatory secondary endpoint to be tested: Health-related quality of life measured with the SF-36 Other secondary endpoints: Depressiveness (PHQ-9) Health-related quality of life in endometriosis (Endometriosis Health Profile (EHP-30)) Impairment due to endometriosis (Endometriosis Impact Questionnaire (EIQ)) Pain interference and intensity according to CPG (Chronic Pain Grade (CPG)) Pain catastrophizing (Pain Catastrophizing Scale (PCS)) Sexual function (The Female Sexual Function Index (FSFI)) Generalized anxiety (Generalized Anxiety Disorder-7 (GAD-7)) Pain coping (Questionnaire for the Assessment of Pain Coping (FESV)) Pain acceptance (Chronic Pain Acceptance Questionnaire (CPAQ)) Psychological flexibility (Questionnaire on Acceptance and Action II (FAH-II)) Pain-specific self-efficacy (Pain Self-Efficacy Questionnaire (PSEQ)) Pain quality (self-report according to DSF) Endometriosis-associated pain (NRS of the Endometriosis Working Group (AGEM)) Medication adherence and utilization of health-related interventions (according to DSF) Patient satisfaction (ZUF-8) Balanced Assessment of Negative Effects of Online Interventions (INEP-ON)

Countries

Germany

Contacts

Public ContactJenny Luisa Grütter

Universität Duisburg-Essen

jenny.gruetter@uni-due.de+49 201 183 6462

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026